Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2008
11/26/2008CN101312648A Cryopreservation of hepatocytes
11/26/2008CN101311267A 新型植物表达构建物 The new plant expression construct
11/26/2008CN101311263A Process for inducing marrow-interstitial stem cells in vitro to be lymphatic endothelial cells
11/26/2008CN101310679A Method for promoting border cell grow to self curing patent interatrial septum foramen ovale
11/26/2008CN100436583C Antifreeze gene from wild rice and its coded protein and application
11/26/2008CN100436580C Variable area gene for single-clone antibody of anti-tumour necrotized factor with high neutralizing activity and preparation thereof
11/26/2008CN100436579C Vitreoscilla hemoglobin gene and its uses
11/26/2008CN100436577C Anterior ocular-associated cell sheet three-dimensional construct and process for producing the same
11/26/2008CN100436482C Long effective amalgamation protein of erythropoietin of human, preparing and purifying methods
11/26/2008CN100436478C Novel pesticidal toxins
11/26/2008CN100435882C System and method for treating cardiac arrhythmias with fibroblast cells
11/26/2008CN100435626C High effective propagation of blattbulume stem node and knottiness axillary bud tissue culture seedling
11/25/2008US7456345 Plants and seeds of corn variety I015022
11/25/2008US7456344 Plants and seeds of corn variety I796483
11/25/2008US7456342 Plants and seeds of corn variety I512243
11/25/2008US7456334 Maize Cr1bio gene promoter and its use to direct root-preferred transgene expression in plants
11/25/2008US7456333 Transgenic non-human mammals that reproduce human pathologies of stem cell origins, such as chromosomal anomalies associated with chronic myeloid leukemia, B-cell acute lymphoblastic leukemia, T-cell acute or lymphoblastic leukemia, or with the migration of hematopoietic or embryonic stem calls.
11/25/2008US7456276 Peptide purification by means of metal ion affinity chromatography
11/25/2008US7456272 Neurotoxins with enhanced target specificity
11/25/2008US7456270 Δ6-desaturase genes and uses thereof
11/25/2008US7456263 P53 binding T cell receptor molecules
11/25/2008US7456261 PRO9830 antibodies
11/25/2008US7456256 Fibronectins; drug screening; treating cardiovascular/nervous system disorders
11/25/2008US7456255 Nogo receptor homologs that decrease inhibition of axonal elongation
11/25/2008US7456161 Use of DHEA and DHEA-sulfate for the treatment of chronic obstructive pulmonary disease
11/25/2008US7456154 Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof
11/25/2008US7456019 Fluid-culture medium is caused to rotate about a horizontal axis with respect to external gravity vector at an angular rate which optimizes orbital path of cells, tissues, and attachment substrates suspended within this culture medium to optimally control collision frequencies, intensities, localization
11/25/2008US7456018 Human hepatoma lines, methods for obtaining same and uses thereof
11/25/2008US7456017 Propagation of liver cells; generate nutrient broths, incubate with modulator, mix with hepatocytes, propagate and recover liver cells
11/25/2008US7456016 Isolated monoclonal antibody produced by hybridoma deposit IDAC accession number 141205-04; customization of therapy for each individual; cell lines; kits
11/25/2008US7456014 Expression vector for use as regulatory tool in genetic engineering; useful for reducing the expression of endogenous mRNA and any substantially similar endogenous mRNA
11/25/2008US7456013 Minichromosomes for use as vectors in plant and animal transformations; artificial chromosomes; autonomous replicating sequences (ars)
11/25/2008US7456008 Modified virus comprising one or more non-native polypeptides
11/25/2008US7456007 β-secretase enzyme compositions and methods
11/25/2008US7456003 Isolated protein having the enzymatic activity of an amylosucrase produced by recombinant DNA
11/25/2008US7456001 A polynucleotide encoding a lipoxygenase and its use for recombinant production of a lipoxygenase; obtaining a lipoxygenase by screening a DNA library with specific probes
11/25/2008US7455999 Synthesizing polyhydroxyalkanoate in a transgenic organism having transgene encoding an enzyme selected from PHB polymerase, PHA polymerase, beta-ketothiolase, beta -ketoacyl-CoA reductase, etc., integrated into chromosome
11/25/2008US7455988 Nucleotide sequences; genetic engineering; controller fusion protein; blocking transcription
11/25/2008US7455983 Nutrient broth for propagation of progenitor cells for use in drug screeniing and human therapy
11/25/2008US7455982 Automated methods of detecting receptor activity
11/25/2008US7455981 Method of detecting broad-spectrum delta-endotoxins
11/25/2008US7455969 Highly permissive cell lines for hepatitis C virus RNA replication
11/25/2008US7455963 Antibodies to cyclin E2 protein
11/25/2008US7455962 Obtaining cells from the aorta-gonad-mesonephros region, detecting cells comprising a podocalyxin-like protein 1-positive phenotype (e.g., using an anti-PCLP1 antibody) and isolating them, and identifying from the isolated cells those having a CD45-negative phenotype
11/25/2008US7455846 Immune potentiating compositions of cancer cells
11/25/2008US7455842 Chimeric West Nile viruses and uses thereof
11/25/2008US7455841 Constitutive transport enhancer (CTE); Rev Responsive element (RRE); coding sequence for HIV-1 Rev, and a coding sequence for a desired protein that comprises a coding sequence for an HIV structural protein that includes an RRE and at least one CTE; genetic vaccines, gene therapy
11/25/2008US7455839 Method of inhibiting the formation of inhibin/betaglycan complexes with an anti-betaglycan antibody
11/25/2008CA2345354C Antisense modulation of bcl-x expression
11/25/2008CA2303416C Repressed trans-activator system for characterization of protein-protein interactions
11/25/2008CA2213697C S-adenosyl-l-homocystein hydrolase promoter
11/20/2008WO2008141207A1 Improved feed media
11/20/2008WO2008140865A1 Method and system for controlling pacemaker therapy
11/20/2008WO2008140863A2 Local field stimulation for cell training of a biological pacemaker
11/20/2008WO2008140814A1 Methods for detecting cardiac damage
11/20/2008WO2008140573A2 Methods for reversibly binding a biotin compound to a support
11/20/2008WO2008140570A2 Antibody with protein a selectivity
11/20/2008WO2008140455A1 Treatment of radiation and chemo-therapy induced fibrosis using novel anti-il 13 monoclonal antibodies
11/20/2008WO2008140414A1 Production of a homogeneous cell line highly permissive to porcine circovirus type 2 (pcv2) infection
11/20/2008WO2008140316A1 Means and methods for enhancing differentiation of haematopoietic progenitor cells
11/20/2008WO2008140296A1 Means and methods for enhancing differentiation of haematopoietic progenitor cells
11/20/2008WO2008140295A1 Cell culture substrate, culture flasks and methods for cell cultivation employing said substrate
11/20/2008WO2008140046A1 Method of degrading biological tissue
11/20/2008WO2008140044A1 Method of degrading biological tissue
11/20/2008WO2008139572A1 Cell isolation method
11/20/2008WO2008139259A2 Fluorescent proteins for monitoring intracellular superoxide production
11/20/2008WO2008139202A1 Neutralizing monoclonal antibody against human dll4
11/20/2008WO2008138994A1 Anti-tumor drug, medicament, composition, and use thereof
11/20/2008WO2008138896A1 A method for sustainable transgene transcription
11/20/2008WO2008138495A1 Method for purifying brush border membrane (bbm) proteins
11/20/2008WO2008138225A1 Cultivation method applying rolling load and bioreactors implementing the method
11/20/2008WO2008138214A1 A method for activation and expansion of lymphocytes with high efficiency and the culture sysytem thereof
11/20/2008WO2008138131A1 Bone targeted alkaline phosphatase, kits and methods of use thereof
11/20/2008WO2008121563A3 Modified fgf-21 polypeptides and their uses
11/20/2008WO2008121422A3 Implantable cell matrix composition for delivery of bioactive compounds
11/20/2008WO2008121199A3 Transgenic animal models of disease
11/20/2008WO2008118820A3 Somatic cell reprogramming
11/20/2008WO2008106644A3 Treatment of diseases characterized by inflammation
11/20/2008WO2008105919A3 Nanomechanical characterization of cellular activity
11/20/2008WO2008103807A3 Methods of producing preadipocytes and increasing the proliferation of adult adipose stem/progenitor cells
11/20/2008WO2008100559A3 Medical devices having a micro-fluidic channeled vasculature
11/20/2008WO2008098184A3 Methods for the induction of a cell to enter the islet 1+ lineage and a method for the expansion thereof
11/20/2008WO2008098183A3 Combination therapy for treating cancer
11/20/2008WO2008097854A3 Method and substances for treating hpv infection
11/20/2008WO2008093280A3 Anti-idiotype monoclonal antibodies as mimotopes of the hiv gp120 antigen
11/20/2008WO2008092153A3 Modification of exosomal components for use as a vaccine
11/20/2008WO2008089094A3 Non-simian cells for growth of porcine reproductive and respiratory syndrome (prrs) virus
11/20/2008WO2008088863A9 Stem cell gene targeting
11/20/2008WO2008085879A3 Stem cell growth media and methods of making and using same
11/20/2008WO2008078157A3 Bioengineered intervertebral discs and methods for their preparation
11/20/2008WO2008070344A3 Compositions and methods for binding sphingosine-1-phosphate
11/20/2008WO2008070179A3 Genes and uses for plant improvement
11/20/2008WO2008070090A3 Compositions and methods for diagnosing and treating cancer
11/20/2008WO2008070082A3 Stem-progenitor cell specific micro-ribonucleic acids and uses thereof
11/20/2008WO2008067408A3 Method of isolating and propagating stem cells from benign tumors
11/20/2008WO2008063934A3 Methods for differentiating insulin-producing beta cells from pancreatic precursor cells
11/20/2008WO2008061261A3 Preparation and use of cell-synthesized threads
11/20/2008WO2008054825A3 Mixed cell populations for tissue repair and separation technique for cell processing
11/20/2008WO2008043033A3 Fibrillation-resistant insulin and insulin analogues
11/20/2008WO2008033866A3 Methods and compositions for the use of lysine riboswitches